Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises DORO SAS in connection with the acquisition of all shares in French based Prylos SAS
Mandate

Vinge advises DORO SAS in connection with the acquisition of all shares in French based Prylos SAS

July 12, 2011

Vinge has advised DORO SAS in connection with its acquisition of all shares in the French based company, Prylos SAS. DORO SAS is a wholly-owned subsidiary of DORO AB, the shares of which are listed on the Nordic List, Small Companies, on OMX NASDAQ Stockholm. Doro focuses on the development, marketing and sale of telecom products which are specifically directed to the elderly. With more than 35 years experience and sales in more than 30 countries on five continents, Doro is a world leading trademark within the field of simple and user-friendly mobile phones. As a result of the acquisition, Doro has acquired an Android-based platform for its product launches and a dedicated development team within telecom solutions for senior citizens.

Vinge’s team advising DORO SAS consisted of partners Johan Winnerblad and Johan Göthberg and associate Nina Farrahi. Partner Karin Grauers provided intellectual property law advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025